Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000152919 | SCV000202347 | benign | not specified | 2014-01-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000152919 | SCV000301889 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000152919 | SCV000521445 | benign | not specified | 2016-09-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000559703 | SCV000645503 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000559703 | SCV001274230 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Ce |
RCV003407572 | SCV004136420 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | CAPN3: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV003407572 | SCV005214516 | likely benign | not provided | criteria provided, single submitter | not provided |